Clinical Trials Logo

Limb Salvage clinical trials

View clinical trials related to Limb Salvage.

Filter by:
  • None
  • Page 1

NCT ID: NCT05223283 Completed - Limb Salvage Clinical Trials

Limb Salvage Post Venous Injury:Case Series

Start date: January 2017
Phase:
Study type: Observational

The venous injury diagnosis depends on history of trauma with symptoms and signs suggestive of venous injuries and color flow duplex study is of increasing value as a screen for detection of an occult venous injuries. It is associated with arterial, peripheral nerve injuries and bone fractures. Within this study of one-year duration, a seventy-five patients with acute venous injuries were included. The injured vein was either repaired or ligated according to hemodynamic state of patient and site and type of injury.

NCT ID: NCT04410042 Terminated - Limb Salvage Clinical Trials

Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure

Start date: January 29, 2021
Phase: Phase 3
Study type: Interventional

This is a randomized double-blind control trial evaluating the use Tranexamic acid (TXA) to decrease blood loss and transfusion requirements in pediatric and young adult cancer patients undergoing a limb salvage procedure that frequently requires perioperative or post-operative transfusions of blood products. Primary Objective - To evaluate the difference in intra-or post-operatively transfused blood volume (mL/kg) for patients undergoing limb salvage procedures of the distal femur or proximal tibia who are randomized to receive perioperative tranexamic acid (TXA) versus placebo. Secondary Objectives - To evaluate changes in platelets and in hemoglobin from pre-op to post-op level for patients randomized to receive perioperative TXA versus placebo. - To evaluate differences in post-operative daily surgical drain output for patients randomized to receive perioperative TXA versus placebo. - To evaluate changes in estimated blood loss (EBL) for patients randomized to receive perioperative TXA versus placebo. - To evaluate the association between the intra-or post-operatively transfused blood volume and estimated blood loss (EBL) for patients randomized to receive perioperative TXA and placebo, respectively. Exploratory Objectives - To evaluate differences in functional outcomes post-operatively for patients randomized to receive perioperative TXA versus placebo. - To explore if significant correlations are observed between parameters reported with rotational thromboelastometry (ROTEM®) and EBL and transfusion requirements in pediatric and young adult patients undergoing limb salvage procedure who are randomized to perioperative TXA versus placebo. - To evaluate differences in the prevalence and management of wound complications such as superficial or periprosthetic infections, wound dehiscence, contact dermatitis, post- operative hematomas, or any other clinically significant wound complication between patients randomized to receive perioperative TXA versus placebo.

NCT ID: NCT03521258 Recruiting - Trauma Clinical Trials

Limb Salvage Through Tissue Engineering: A Novel Treatment Modality Using Dehydrated Human Amnion/Chorion Membrane

Start date: February 2016
Phase: N/A
Study type: Interventional

Extremity wounds with exposed critical structures, including bone and tendon are a major burden on the American healthcare system with limited treatment options. Free Flap reconstructions of lower extremity wounds have an increased failure rate in comparison to elective free flap procedures.These procedures are long and are associated with a high cost of care, prolonged hospital stays, and are limited by the need for surgical specialist availability and patient vessels suitable for anastomoses. This study will use a new treatment modality which is a commercially ready human amniotic membrane allograft (EpiFix) to promote a granulation tissue wound base that will be suitable for skin grafting, thus forgoing the need for a flap-based for reconstruction. The study goals are to reduce the overall cost of providing definitive treatment by decreasing operative time, length of hospital stay, decrease the need for intensive nursing care and rehabilitation. This study will aim to provide a treatment option that is readily accessible to all patients with these complex wounds in any healthcare setting across the country.

NCT ID: NCT03107728 Recruiting - Lower Extremity Clinical Trials

The IM ABLE Study: A Study of Warriors & Veterans Following Neuromusculoskeletal Injury of the Lower Limb

Start date: February 22, 2018
Phase: N/A
Study type: Interventional

The purpose of the IM ABLE(Injuries Managed with Advanced Bracing for Lower Extremities) study is to determine if advanced (ADV) ankle foot orthoses (AFOs) will enable users to achieve greater levels of physical and self-reported function compared with conventional (CONV) AFOs for those ambulating at or above the independent community level of ambulation.

NCT ID: NCT02536053 Completed - Limb Salvage Clinical Trials

Outcomes in Lower Extremity Soft Tissue Sarcoma Patients After Limb Salvage

Start date: December 2015
Phase:
Study type: Observational

This study aims to: 1. validate the Finnish version of the Musculoskeletal Tumor Society scale and the Toronto Extremity Salvage Score lower extremity sections and to 2. assess the functional ability and health-related quality of life (HRQoL) of lower extremity sarcoma patients who have undergone limb salvage surgery.

NCT ID: NCT02372838 Completed - Limb Salvage Clinical Trials

Reconstruction of Extensive Upper Extremity Long Bone Defects With a Microvascular Fibula Flap

Start date: June 2014
Phase: N/A
Study type: Observational

This study assesses the long-term functional outcomes of upper extremity long bone defects treated with the free fibula bone transfer.

NCT ID: NCT02372825 Completed - Limb Salvage Clinical Trials

Role of Free Iliac Crest Flap in Heel and Ankle Reconstruction

Start date: June 2014
Phase: N/A
Study type: Observational [Patient Registry]

Treatment of extensive traumatic acute bone defects or sequela in heel or ankle poses a formidable challenge for the reconstructive surgeon. These defects can be treated with the vascularized iliac crest transfer. The purpose of this study is to assess the reliability and the long-term outcomes of free iliac crest flap transfer for these indications.

NCT ID: NCT01133145 Enrolling by invitation - Limb Salvage Clinical Trials

Allogeneic Vascularized Knee Transplantation

kneeTx
Start date: n/a
Phase: N/A
Study type: Interventional

High energy trauma often results in severe soft tissue, bone and joint injury. Today, many methods and techniques exist to treat theses severely injured extremities. Surgical techniques include open reduction and internal fixation (ORIF), e.g. with screws and plates, soft tissue reconstruction by local or free flaps and joint reconstruction by arthroplasty, e.g. total knee arthroplasty. In few, very severe cases, those methods are not sufficient to restore function and amputation is the only option left. In 1908 the German surgeon Erich Lexer had the idea to transplant a joint. Due to the medical situation at his time the attempts failed. But the idea survived and was processed over the time. Transplant surgery and medicine developed, immunosuppressive drugs were established and animal models proved that bone and joint transplantation is technically feasible. In 1998 the first successful hand and in 2005 the first partial face transplantation was carried out. In 1996 we started our clinical femur and knee joint transplantation project.